Shenzhu Guanxin formula alleviates atherosclerosis in rats via PI3K/Akt pathway inhibition: a comparative study of decoction and granule forms
{{output}}
Shenzhu Guanxin Formula (SGF), a traditional Chinese medicinal compound comprising nine classical herbal constituents, has demonstrated clinical efficacy in the treatment of coronary heart disease. However, its bioactive components and mechanistic underpinning... ...